Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1341-1350 of 1,553) with videos related to

Pageof 156
Sort By:
Cancer Biology & Medicine|September 27, 2021
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancerYujiao Wang, Xi Jiao, Shuang Li, et al.
Cancer Biology & Medicine|January 20, 2025
Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centersZhihao Lu, Mingfei Geng, Yongtao Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase TrialsChangsong Qi, Panpan Zhang, Chang Liu, et al.
Gastroenterology Report|September 27, 2021
A multicenter study assessing the prevalence of germline genetic alterations in Chinese gastric-cancer patientsYin-Jie Zhang, Yang Yang, Qing Wei, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2019
Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in ChinaMengfei Liu, Zhen Liu, Fangfang Liu, et al.
Clinical and Translational Gastroenterology|March 3, 2025
An Image-Based Model for Assisting in Diagnosing Malignant Esophageal Lesions During Lugol Chromoendoscopic ExaminationMengfei Liu, Zifan Qi, Ren Zhou, et al.
European Radiology|November 10, 2023
CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumorsJiazheng Li, Shaoqing Huang, Hui Zhu, et al.
BMC Medicine|July 6, 2026
Effect of endoscopic screening for non-cardia gastric cancer: a 12-year report of a population-based randomized trialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trialsJingyuan Wang, Yi Xiao, Fotios Loupakis, et al.
The Lancet. Oncology|November 7, 2017
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trialYung-Jue Bang, Rui-Hua Xu, Keisho Chin, et al.
Pageof 156

Showing results (1341-1350 of 1,553) with videos related to

Sort By:
Pageof 156
Cancer Biology & Medicine|September 27, 2021
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancerYujiao Wang, Xi Jiao, Shuang Li, et al.
Cancer Biology & Medicine|January 20, 2025
Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centersZhihao Lu, Mingfei Geng, Yongtao Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase TrialsChangsong Qi, Panpan Zhang, Chang Liu, et al.
Gastroenterology Report|September 27, 2021
A multicenter study assessing the prevalence of germline genetic alterations in Chinese gastric-cancer patientsYin-Jie Zhang, Yang Yang, Qing Wei, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2019
Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in ChinaMengfei Liu, Zhen Liu, Fangfang Liu, et al.
Clinical and Translational Gastroenterology|March 3, 2025
An Image-Based Model for Assisting in Diagnosing Malignant Esophageal Lesions During Lugol Chromoendoscopic ExaminationMengfei Liu, Zifan Qi, Ren Zhou, et al.
European Radiology|November 10, 2023
CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumorsJiazheng Li, Shaoqing Huang, Hui Zhu, et al.
BMC Medicine|July 6, 2026
Effect of endoscopic screening for non-cardia gastric cancer: a 12-year report of a population-based randomized trialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trialsJingyuan Wang, Yi Xiao, Fotios Loupakis, et al.
The Lancet. Oncology|November 7, 2017
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trialYung-Jue Bang, Rui-Hua Xu, Keisho Chin, et al.
Pageof 156